Center for Substance Abuse Treatment (CSAT). Detoxification and substance abuse treatment. Treatment Improvement Protocol (TIP) Series 45. DHHS Publication No. (SMA) 06–4131. Rockville: Substance Abuse and Mental Health Services Administration; 2006. https://store.samhsa.gov/shin/content/SMA13-4131/SMA13-4131.pdf. Accessed 11 Dec 2016
Substance Abuse and Mental Health Services Administration (SAMHSA). Treatments for substance use disorders. Rockville: Substance Abuse and Mental Health Services Administration; 2016. https://www.samhsa.gov/treatment/substance-use-disorders. Accessed 12 Oct 2017
Substance Abuse and Mental Health Services Administration (SAMHSA). Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2004–2014. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-84, HHS Publication No. (SMA) 16-4986. Rockville: Substance Abuse and Mental Health Services Administration; 2016. https://wwwdasis.samhsa.gov/dasis2/teds_pubs/2014_teds_rpt_natl.pdf. Accessed 12 Oct 2017
National Institute of Drug Abuse (NIDA). Principles of drug addiction treatment: a research-based guide. 3rd ed; 2012. https://www.drugabuse.gov/publications/principles-drug-addiction-treatment-research-based-guide-third-edition. Accessed 10 Mar 2017
Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348:1786–95.
Stein BD, Kogan JN, Sorbero M. Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment. Drug Alcohol Depend. 2009;104:100–6.
Timko C, Schultz NR, Britt J, Cucciare MA. Transitioning from detoxification to substance use disorder treatment: facilitators and barriers. J Subst Abus Treat. 2016;70:64–72.
Wu LT, Ling W, Burchett B, Blazer DG, Shostak J, Woody GE. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network. Subst Abuse Rehabil. 2010;1:13–22.
Day E, Strang J. Outpatient versus inpatient opioid detoxification: a randomized controlled trial. J Subst Abus Treat. 2011;40:56–66.
Hayashida M. An overview of outpatient and inpatient detoxification. Alcohol Health Res World. 1998;22:44–6.
Mark TL, Dilonardo JD, Chalk M, Coffey RM. Trends in inpatient detoxification services, 1992–1997. J Subst Abus Treat. 2002;23:253–60.
Center for Behavioral Health Statistics and Quality (CBHSQ). 2015 National Survey on Drug Use and Health: detailed tables. Rockville: Substance Abuse and Mental Health Services Administration; 2016. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf. Accessed 12 Oct 2017
Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2015. NCHS data brief, no 273. Hyattsville: National Center for Health Statistics; 2017. https://www.cdc.gov/nchs/products/databriefs/db273.htm. Accessed 15 Aug 2017
Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1445–52.
Gostin LO, Hodge JG Jr, Noe SA. Reframing the opioid epidemic as a national emergency. JAMA. 2017;318:1539–40.
Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. JAMA. 2015;314:1453–4.
Schuchat A, Houry D, Guy GP. New data on opioid use and prescribing in the United States. JAMA. 2017;318:425–6.
Callaghan RC, Cunningham JA. Gender differences in detoxification: predictors of completion and re-admission. J Subst Abus Treat. 2002;23:399–407.
Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–27.
Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on alcohol and related conditions–III. JAMA Psychiatry. 2016;73:39–47.
Haley SJ, Dugosh KL, Lynch KG. Performance contracting to engage detoxification-only patients into continued rehabilitation. J Subst Abus Treat. 2011;40:123–31.
Carrier E, McNeely J, Lobach I, Tay S, Gourevitch MN, Raven MC. Factors associated with frequent utilization of crisis substance use detoxification services. J Addict Dis. 2011;30:116–22.
Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174:1369–76.
Mark T, Vandivort-Warren R, Stocks C, Levit K, Owens P, Buck J, Coffey R. Treatment for substance use disorders in community hospitals: U.S. Agency for Healthcare Research and Quality (AHRQ); 2010. http://www.hcup-us.ahrq.gov/reports.jsp. Accessed 12 Oct 2017
Reif S, Acevedo A, Garnick DW, Fullerton CA. Reducing behavioral health inpatient readmissions for people with substance use disorders: do follow-up services matter? Psychiatr Serv. 2017;68:810–8.
Day E, Ison J, Strang J. Inpatient versus other settings for detoxification for opioid dependence. Cochrane Database Syst Rev. 2005:Art. No.: CD004580. https://doi.org/10.1002/14651858.CD004580.pub2.
Campbell BK, Tillotson CJ, Choi D, Bryant K, DiCenzo J, Provost SE, et al. Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abus Treat. 2010;38(Suppl 1):S87–96.
Mark TL, Dilonardo JD, Chalk M, Coffey R. Factors associated with the receipt of treatment following detoxification. J Subst Abus Treat. 2003;24:299–304.
Nosyk B, Li L, Evans E. Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991–2012. Drug Alcohol Depend. 2014;143:149–57.
Alfandre DJ. “I’m going home”: discharges against medical advice. Mayo Clin Proc. 2009;84:255–60.
Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, et al. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med. 2012;6:50–6.
Kenne DR, Boros AP, Fischbein RL. Characteristics of opiate users leaving detoxification treatment against medical advice. J Addict Dis. 2010;29:383–94.
Blondell RD, Amadasu A, Servoss TJ, Smith SJ. Differences among those who complete and fail to complete inpatient detoxification. J Addict Dis. 2006;25:95–104.
Wines JD, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007;89:161–9.
Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375:357–68.
HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville: Agency for Healthcare Research and Quality; 2011. www.hcup-us.ahrq.gov/nisoverview.jsp
American Hospital Association (AHA). Fast facts on US hospitals. 2017. http://www.aha.org/research/rc/stat-studies/fast-facts.shtml. Accessed 04 Jan 2017.
Centers for Medicare and Medicaid Services (CMS). ICD-9-CM Diagnosis and Procedure Codes: Abbreviated and Full Code Titles. 2014. https://www.cms.gov/medicare/coding/ICD9providerdiagnosticcodes/codes.html. Accessed 07 Apr 2016.
Yoshihara H, Yoneoka D. Understanding the statistics and limitations of large database analyses. Spine. 2014;39:1311–2.
Stata [computer program]. Release 13. College Station: StataCorp LP; 2013.
Ford LK, Zarate P. Closing the gaps: the impact of inpatient detoxification and continuity of care on client outcomes. J Psychoactive Drugs. 2010;42:303–14.
Acevedo A, Lee MT, Garnick DW, Horgan CM, Ritter GA, Panas L, et al. Agency-level financial incentives and electronic reminders to improve continuity of care after discharge from residential treatment and detoxification. Drug Alcohol Depend. 2017;183:192–200.
Quinn AE, Hodgkin D, Perloff JN, Stewart MT, Brolin M, Lane N, et al. Design and impact of bundled payment for detox and follow-up care. J Subst Abus Treat. 2017;82:113–21.
Steenrod S, Brisson A, McCarty D, Hodgkin D. Effects of managed care on programs and practices for the treatment of alcohol and drug dependence. Recent Dev Alcohol. 2001;15:51–71.
American Society of Addiction Medicine (ASAM). ASAM patient placement criteria for the treatment of substance-related disorders, 2nd-revised (ASAM PPC-2R). Chevy Chase: American Society of Addiction Medicine; 2001.
Maclean JC, Saloner B. The effect of public insurance expansions on substance use disorder treatment: evidence from the affordable care act. (no. w23342). Nat Bureau Econ Res. http://www.nber.org/papers/w23342. Accessed 20 Nov 2017
Spear SE. Reducing readmissions to detoxification: an interorganizational network perspective. Drug Alcohol Depend. 2014;137:76–82.
Green P, Watts D, Poole S, Dhopesh V. Why patients sign out against medical advice (AMA): factors motivating patients to sign out AMA. Am J Drug Alcohol Abuse. 2004;30:489–93.
Centers for Medicare and Medicaid Services (CMS). About section 1115 demonstrations. 2015. https://www.medicaid.gov/medicaid/section-1115-demo/about-1115/index.html. Accessed 09 Mar 2017.
Padwa H, Urada D, Gauthier P, Rieckmann T, Hurley B, Crèvecouer-MacPhail D, et al. Organizing publicly funded substance use disorder treatment in the United States: moving toward a service system approach. J Subst Abus Treat. 2016;69:9–18.
Hughes A, Williams MR, Lipari RN, Bose J, Copello EAP, Kroutil LA. Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. 2016. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR2-2015/NSDUH-FFR2-2015.htm. Accessed 08 Apr 2017.
Stevens JP, Wall MJ, Novack L, Marshall J, Hsu DJ, Howell MD. The critical care crisis of opioid overdoses in the United States. Ann Am Thorac Soc. 2017;14:1803–9.
Naeger S, Mutter R, Ali MM, Mark T, Hughey L. Post-discharge treatment engagement among patients with an opioid-use disorder. J Subst Abus Treat. 2016;69:64–71.
Wu LT, Woody GE, Yang C, Mannelli P, Blazer DG. Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on alcohol and related conditions. Subst Abuse Rehabi. 2011;2:77–88.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624–45.
Koh HK. Community-based prevention and strategies for the opioid crisis. JAMA. 2017;318:993–4.
Krawczyk N, Feder KA, Saloner B, Crum RM, Kealhofer M, Mojtabai R. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample. Drug Alcohol Depend. 2017;175:157–63.
Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012;37:11–24.
Knickman J, Krishnan R, Pincus H. Improving access to effective care for people with mental health and substance use disorders. JAMA. 2016;316:1647–8.
Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS): 2013. Data on substance abuse treatment facilities. BHSIS Series S-73, HHS Publication No. (SMA) 14–489. Rockville: Substance Abuse and Mental Health Services Administration; 2014. https://www.samhsa.gov/data/sites/default/files/2013_N-SSATS/2013_N-SSATS_National_Survey_of_Substance_Abuse_Treatment_Services.pdf. Accessed 10 Mar 2017
Clark RE, Samnaliev M, McGovern MP. Impact of substance disorders on medical expenditures for Medicaid beneficiaries with behavioral health disorders. Psychiatr Serv. 2009;60:35–42.
Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59:375–80.
Mojtabai R, Chen LY, Kaufmann CN, Crum RM. Comparing barriers to mental health treatment and substance use disorder treatment among individuals with comorbid major depression and substance use disorders. J Subst Abus Treat. 2014;46:268–73.
Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD. Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abus Treat. 2016;61:47–59.
United States Census Bureau. QuickFacts. 2018. https://www.census.gov/quickfacts/fact/table/US/PST045216. Accessed 31 May 2018.